thioctic acid and Substance Withdrawal Syndrome studies

thioctic acid and Substance Withdrawal Syndrome

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

Excerpt	Relevance	Reference
"Morphine treatment increased MDA levels."	1.35	Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration. ( Cighetti, G; Pinelli, A; Trivulzio, S, 2008)

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

2 (50.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (50.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Pinelli, A	2
Cighetti, G	2
Trivulzio, S	2
Barth, L	1
Brinkmann, W	1
Klein, B	1
Möller, E	1

Studies

Pinelli, A

Cighetti, G

Trivulzio, S

Barth, L

Brinkmann, W

Klein, B

Möller, E

Trials

1 trial available for thioctic acid and Substance Withdrawal Syndrome

Article	Year
[Is the rebound effect in liver diseases following glucocorticoid therapy avoidable by using alpha-lipoic acid?]. Therapie der Gegenwart, 1971, Volume: 110, Issue:12 Topics: Chronic Disease; Drug Interactions; Humans; Liver Diseases; Paramethasone; Substance Withdrawal Synd	1971

Article

Year

[Is the rebound effect in liver diseases following glucocorticoid therapy avoidable by using alpha-lipoic acid?].

Therapie der Gegenwart, 1971, Volume: 110, Issue:12

Topics: Chronic Disease; Drug Interactions; Humans; Liver Diseases; Paramethasone; Substance Withdrawal Synd

1971

Other Studies

3 other studies available for thioctic acid and Substance Withdrawal Syndrome

Article	Year
Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration. Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:4 Topics: Animals; Antioxidants; Behavior, Animal; Defecation; Dose-Response Relationship, Drug; Drug Interact	2008
Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone. Arzneimittel-Forschung, 2009, Volume: 59, Issue:2 Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Blood Glucose; Defecation; Male; Malond	2009
[Treatment of acute incidents in drug addiction]. Der Nervenarzt, 1972, Volume: 43, Issue:5 Topics: Apnea; Ascorbic Acid; Coma; Diazepam; Drug Combinations; Humans; Psychomotor Disorders; Psychoses, S	1972

Article

Year

Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.

Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:4

Topics: Animals; Antioxidants; Behavior, Animal; Defecation; Dose-Response Relationship, Drug; Drug Interact

2008

Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.

Arzneimittel-Forschung, 2009, Volume: 59, Issue:2

Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Blood Glucose; Defecation; Male; Malond

2009

[Treatment of acute incidents in drug addiction].

Der Nervenarzt, 1972, Volume: 43, Issue:5

Topics: Apnea; Ascorbic Acid; Coma; Diazepam; Drug Combinations; Humans; Psychomotor Disorders; Psychoses, S

1972